Skip to main content
Log in

Prognostic value of pulmonary hypertension in pre-dialysis chronic kidney disease patients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background

Pulmonary hypertension is common in chronic kidney disease (CKD) patients. However, the prognostic value of pulmonary hypertension in Chinese predialytic CKD patients is rarely reported. We evaluated the relevant factors and prognostic value of pulmonary hypertension in CKD patients.

Methods

This retrospective cohort study enrolled 1092 predialytic patients from The Third Affiliated Hospital of Sun Yat-Sen University from May 1st, 2011, to December 31st, 2016. Data of interest were retrieved from electronic medical records. Pulmonary hypertension was defined as pulmonary arterial systolic pressure (PASP) ≥ 35 mmHg by echocardiology. All participants were followed from the date of the first echocardiography examination. The primary endpoints were all-cause mortality and cardiovascular mortality. The secondary endpoint was end-stage renal disease (ESRD) defined as starting renal replacement therapy.

Results

The prevalence of pulmonary hypertension was 15.9% in the study population. For CKD stage 1, 2, 3a, 3b, 4 and 5, the prevalence was 6.0%, 9.6%, 17.2%, 13.3%, 20.7% and 26.6%, respectively. Older age, lower left ventricular ejection fraction, anemia and higher pulse pressure were independently associated with pulmonary hypertension in CKD patients. In multivariate Cox regression analysis, pulmonary hypertension was the independent risk factor for cardiovascular mortality, but not of all-cause mortality and ESRD.

Conclusions

Pulmonary hypertension is not rare in early CKD patients. Patients with older age, anemia, higher pulse pressure and compromised heart function were more likely to comorbid pulmonary hypertension. Pulmonary hypertension maybe a sign of worse cardiovascular outcome in CKD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. National Institutes Of Health (2016) United States Renal Data System. 2016 USRDS annual data report: epidemiology of kidney disease in the United States

  2. Zhang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. The Lancet 379:815–822. https://doi.org/10.1016/S0140-6736(12)60033-6

    Article  Google Scholar 

  3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305. https://doi.org/10.1056/NEJMoa041031

    Article  CAS  PubMed  Google Scholar 

  4. He Y, Wang Y, Luo X, Ke J, Du Y, Li M (2015) Risk factors for pulmonary hypertension in maintenance hemodialysis patients: a cross-sectional study. Int Urol Nephrol 47:1889–1897. https://doi.org/10.1007/s11255-015-1119-5

    Article  CAS  PubMed  Google Scholar 

  5. Li Z et al (2014) Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients. Int Urol Nephrol 46:141–149. https://doi.org/10.1007/s11255-013-0486-z

    Article  CAS  PubMed  Google Scholar 

  6. Agarwal R (2012) Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transpl 27:3908–3914. https://doi.org/10.1093/ndt/gfr661

    Article  Google Scholar 

  7. Zeng Y et al (2016) Risk factors for pulmonary hypertension in patients receiving maintenance peritoneal dialysis. Braz J Med Biol Res 49:e4733. https://doi.org/10.1590/1414-431X20154733

    Article  PubMed Central  Google Scholar 

  8. Zhang L et al (2016) Prevalence and risk factors for pulmonary arterial hypertension in end-stage renal disease patients undergoing continuous ambulatory peritoneal dialysis. Ren Fail 38:815–821. https://doi.org/10.3109/0886022X.2015.1103637

    Article  CAS  PubMed  Google Scholar 

  9. Xu Q et al (2015) Association of pulmonary hypertension with mortality in incident peritoneal dialysis patients. Perit Dial Int 35:537–544. https://doi.org/10.3747/pdi.2013.00332

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Unal A et al (2009) Pulmonary hypertension in peritoneal dialysis patients: prevalence and risk factors. Perit Dial Int 29:191–198

    Article  PubMed  Google Scholar 

  11. Navaneethan SD et al (2016) Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol 27:877–886. https://doi.org/10.1681/ASN.2014111111

    Article  CAS  PubMed  Google Scholar 

  12. Shang W, Li Y, Ren Y, Li W, Wei H, Dong J (2018) Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis. Int Urol Nephrol 50:1497–1504. https://doi.org/10.1007/s11255-018-1853-6

    Article  PubMed  Google Scholar 

  13. Tang M, Batty JA, Lin C, Fan X, Chan KE, Kalim S (2018) Pulmonary hypertension, mortality, and cardiovascular disease in CKD and ESRD patients: a systematic review and meta-analysis. Am J Kidney Dis 72:75–83. https://doi.org/10.1053/j.ajkd.2017.11.018

    Article  PubMed  Google Scholar 

  14. Simonneau G et al (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:D34–D41. https://doi.org/10.1016/j.jacc.2013.10.029

    Article  PubMed  Google Scholar 

  15. KDIGO 2012 (2013) Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney disease: improving global outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. 3:1–150

  16. Matsushita K et al (2012) Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307:1941–1951. https://doi.org/10.1001/jama.2012.3954

    Article  CAS  PubMed  Google Scholar 

  17. Levey AS et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612

    Article  PubMed  PubMed Central  Google Scholar 

  18. Lang RM et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463. https://doi.org/10.1016/j.echo.2005.10.005

    Article  PubMed  Google Scholar 

  19. Li Z et al (2014) Pulmonary hypertension: epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS ONE 9:e114392. https://doi.org/10.1371/journal.pone.0114392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kinoshita T, Tawa M, Suzuki T, Aimi Y, Asai T, Okamura T (2017) Endothelial dysfunction of internal thoracic artery graft in patients with chronic kidney disease. J Thorac Cardiovasc Surg 153:317–324. https://doi.org/10.1016/j.jtcvs.2016.09.037

    Article  CAS  PubMed  Google Scholar 

  21. Kim SC, Chang HJ, Kim MG, Jo SK, Cho WY, Kim HK (2015) Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients. Kidney Res Clin Pract 34:28–34. https://doi.org/10.1016/j.krcp.2015.01.003

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bolignano D et al (2013) Pulmonary hypertension in CKD. Am J Kidney Dis 61:612–622. https://doi.org/10.1053/j.ajkd.2012.07.029

    Article  PubMed  Google Scholar 

  23. Forhecz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohaszka Z, Janoskuti L (2009) Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J 158:659–666. https://doi.org/10.1016/j.ahj.2009.07.024

    Article  PubMed  Google Scholar 

  24. Shah N, Pahuja M, Pant S, Handa A, Agarwal V, Patel N, Dusaj R (2017) Red cell distribution width and risk of cardiovascular mortality: Insights from National Health and Nutrition Examination Survey (NHANES)-III. Int J Cardiol 232:105–110. https://doi.org/10.1016/j.ijcard.2017.01.045

    Article  PubMed  Google Scholar 

  25. Rhodes CJ, Wharton J, Howard LS, Gibbs JSR, Wilkins MR (2011) Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart 97:1054–1060. https://doi.org/10.1136/hrt.2011.224857

    Article  CAS  PubMed  Google Scholar 

  26. Felker GM et al (2007) Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 50:40–47. https://doi.org/10.1016/j.jacc.2007.02.067

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yu Peng or Hui Peng.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Human or animal rights

All procedures performed in studies involving human participants were in accordance with the ethical standards of the ethics committee of The Third Affiliated Hospital of Sun Yat-sen University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

The ethics committee approved that informed consent could be waived due to retrospective study design.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, X., Zhao, W., Ma, X. et al. Prognostic value of pulmonary hypertension in pre-dialysis chronic kidney disease patients. Int Urol Nephrol 52, 2329–2336 (2020). https://doi.org/10.1007/s11255-020-02589-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-020-02589-6

Keywords

Navigation